MLK3 promotes melanoma proliferation and invasion and is a target of microRNA-125b

Clinical and Experimental Dermatology

Volumn 39, Issue 3, 2014, Pages 376-384

  Zhang, J ^a   Lu, L ^b   Xiong, Y ^a   Qin, W ^b   Zhang, Y ^b   Qian, Y ^b   Jiang, H ^b   Liu, W ^a  

^a NANCHANG UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 125B; MIXED LINEAGE KINASE 3; MESSENGER RNA; PROTEIN C JUN; SMALL INTERFERING RNA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE;

ARTICLE; BIOINFORMATICS; CANCER GROWTH; CELL CULTURE; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; LUCIFERASE ASSAY; MELANOMA CELL; METASTATIC MELANOMA; MTS ASSAY; PLASMID; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; 3' UNTRANSLATED REGION; COMPARATIVE STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN CELL; MAJOR CLINICAL STUDY; MELANOMA; MELANOMA CELL LINE; QUANTITATIVE ANALYSIS; STABLE EXPRESSION; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; SKIN TUMOR; TUMOR CELL LINE;

BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MAP KINASE KINASE KINASES; MELANOMA; MICRORNAS; NEOPLASM INVASIVENESS; SKIN NEOPLASMS;

EID: 84898953297     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12286     Document Type: Article

References (29)

1. Myles ZM, Buchanan N, King JB, et al,. Anatomic distribution of malignant melanoma on the non-Hispanic black patient, 1998-2007. Arch Dermatol 2012; 148: 797-801.
2. Gray-Schopfer V, Wellbrock C, Marais R,. Melanoma biology and new targeted therapy. Nature 2007; 445: 851-7.
3. Melnikova VO, Bar-Eli M,. Transcriptional control of the melanoma malignant phenotype. Cancer Biol Ther 2008; 7: 997-1003.
4. Garnett MJ, Rana S, Paterson H, et al,. Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization. Mol Cell 2005; 20: 963-9. (Pubitemid 41814884)
5. Sonoda Y, Warita M, Suzuki T, et al,. Proteolipid protein 2 is associated with melanoma metastasis. Oncol Rep 2010; 23: 371-6.
6. Wu FH, Yuan Y, Li D, et al,. Endothelial cell-expressed Tim-3 facilitates metastasis of melanoma cells by activating the NF-kappaB pathway. Oncol Rep 2010; 24: 693-9.
7. Sui Z, Fan S, Sniderhan L, et al,. Inhibition of mixed lineage kinase 3 prevents HIV-1 Tat-mediated neurotoxicity and monocyte activation. J Immunol 2006; 177: 702-11. (Pubitemid 43939185)
8. Brancho D, Ventura JJ, Jaeschke A, et al,. Role of MLK3 in the regulation of mitogen-activated protein kinase signaling cascades. Mol Cell Biol 2005; 25: 3670-81. (Pubitemid 40559573)
9. Chadee DN, Kyriakis JM,. MLK3 is required for mitogen activation of B-Raf, ERK and cell proliferation. Nat Cell Biol 2004; 6: 770-6. (Pubitemid 39144483)
10. Thylur RP, Senthivinayagam S, Campbell EM, et al,. Mixed lineage kinase 3 modulates beta-catenin signaling in cancer cells. J Biol Chem 2011; 286: 37470-82.
11. Sathyanarayana P, Barthwal MK, Kundu CN, et al,. Activation of the Drosophila MLK by ceramide reveals TNF-alpha and ceramide as agonists of mammalian MLK3. Mol Cell 2002; 10: 1527-33. (Pubitemid 36050893)
12. Mueller DW, Bosserhoff AK,. Role of miRNAs in the progression of malignant melanoma. Br J Cancer 2009; 101: 551-6.
13. Garzon R, Calin GA, Croce CM,. MicroRNAs in Cancer. Annu Rev Med 2009; 60: 167-79.
14. Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M,. microRNAs in cancer management. Lancet Oncol 2012; 13: e249-58.
15. Dyrskjot L, Ostenfeld MS, Bramsen JB, et al,. Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 2009; 69: 4851-60.
16. Zhu XC, Dong QZ, Zhang XF, et al,. microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma. Int J Mol Med 2012; 30: 1321-6.
17. Mueller DW, Rehli M,. Bosserhoff AK miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J Invest Dermatol 2009; 129: 1740-51.
18. Gaur A, Jewell DA, Liang Y, et al,. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 2007; 67: 2456-68. (Pubitemid 46548930)
19. Lu J, Getz G, Miska EA, et al,. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 83-8.
20. Kappelmann M, Kuphal S, Meister G, et al,. MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression. Oncogene 2013; 32: 2984-91.
21. Glud M, Rossing M, Hother C, et al,. Downregulation of miR-125b in metastatic cutaneous malignant melanoma. Melanoma Res 2010; 20: 479-84.
22. Glud M, Manfe V, Biskup E, et al,. MicroRNA miR-125b induces senescence in human melanoma cells. Melanoma Res 2011; 21: 253-6.
23. Jacob K, Wach F, Holzapfel U, et al,. In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid. Melanoma Res 1998; 8: 211-19. (Pubitemid 28313758)
24. Rangasamy V, Mishra R, Sondarva G, et al,. Mixed-lineage kinase 3 phosphorylates prolyl-isomerase Pin1 to regulate its nuclear translocation and cellular function. Proc Natl Acad Sci USA 2012; 109: 8149-54.
25. Chen J, Miller EM, Gallo KA,. MLK3 is critical for breast cancer cell migration and promotes a malignant phenotype in mammary epithelial cells. Oncogene 2010; 29: 4399-411.
26. Chen J, Gallo KA,. MLK3 regulates paxillin phosphorylation in chemokine-mediated breast cancer cell migration and invasion to drive metastasis. Cancer Res 2012; 72: 4130-40.
27. Zou W, Greenblatt MB, Shim JH, et al,. MLK3 regulates bone development downstream of the faciogenital dysplasia protein FGD1 in mice. J Clin Invest 2011; 121: 438-92.
28. Gong J, Zhang JP, Li B, et al,. MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R. Oncogene 2013; 32: 2984-91.
29. Kappelmann M, Kuphal S, Meister G, et al,. MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression. Oncogene 2013; 32: 3071-9.